Switch View
© BusinessWire
06.11.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Deadline Soon: Savara Inc. (SVRA) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming November 7, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA) securities between March 7, 2024 and May 23, 2025, inclusive (the “Class Period...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Molina Healthcare
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of do...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: DE000BAY0017
Bayer AG
BAYN
LISTED
XETR
Dr. Judith Hartmann to Become New Chief Financial Officer of Bayer AG
News Preview
The Supervisory Board of Bayer AG has appointed Dr. Judith Hartmann to the company’s Board of Management, effective March 1, 2026. She will succeed Wolfgang Nickl as the company’s Chief Financial Officer (CFO) on June 1, 2026, following his planned retirement at the end of May 2026. Dr. Hartmann is currently an Operating Partner at Sandbrook Capit...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
06.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Avantor
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars fo...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
06.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at MoonLake Immunotherapeutics
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Reuters Research Inc. (“MoonLake” or the “Company”) (NASDAQ: MLTX).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Cytokinetics
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cytokinetics, Incorporated (“Cytokinetics” or the “Company”) (NASDAQ: CYTK).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of mi...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: IS0000000040
Embla Medical hf
EMBLA
LISTED
CPH
Embla Medical Expands Support for Ukrainian Amputees with New Kyiv Clinic and Iceland Partnership
News Preview
REYKJAVIK, Iceland and COPENHAGEN, Denmark, Nov. 6, 2025 /PRNewswire/ -- Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced the official opening of its new prosthetic clinic in Kyiv.
At the clinic's opening ceremony, Embla Medical...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: FR0000121667
EssilorLuxottica SA
EL
LISTED
EURONEXT
EssilorLuxottica expands its myopia management platform with Essilor Stellest 2.0 lenses, smart glasses and an innovative pre-myopia solution
News Preview
EssilorLuxottica expands its myopia management platform with Essilor Stellest 2.0 lenses, smart glasses and an innovative pre-myopia solution...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Lantheus
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Jasper Therapeutics
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Savara
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at aTyr Pharma
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against aTyr Pharma, Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
06.11.2025
ISIN: US1407553072
Tvardi Therapeutics Inc
TVRD
LISTED
NASDAQ
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Tvardi
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Tvardi Therapeutics, Inc.. (“Tvardi” or the “Company”) (NASDAQ: TVRD).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
California Seniors Now Have More Medicare Advantage and Medicare Prescription Drug Plans to Choose from in 2026 Thanks to Health Net and Centene
News Preview
Health Net to offer health plans for seniors in 13 select California counties
Nationally, Centene's Wellcare health plan will be available to more than 51 million beneficiaries in 32 states across more than 1,850 counties, including 13 in California...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: FR0010259150
Ipsen SA
IPN
LISTED
EURONEXT
IPSEN - Buy-back programme - Art 5 of MAR - Week 44 - 2025
News Preview
Attachment...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US89422G1076
Travere Therapeutics Inc
TVTX
LISTED
NASDAQ
Travere Therapeutics Announces Late-Breaking Data from Phase 3 DUPLEX Study of FILSPARI in FSGS Presented at the American Society of Nephrology (ASN) Kidney Week 2025
News Preview
Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced new data from the Phase 3 DUPLEX Study demonstrating that patients with focal segmental glomerulosclerosis (FSGS) treated with FILSPARI® (sparsentan) were significantly more likely to reach proteinuria levels below 0.7 g/g compared to those receiving the maximum labeled dose of irbesartan,...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.11.2025
ISIN: US18507C1036
Clearpoint Neuro Inc
CLPT
LISTED
NASDAQ
ClearPoint Neuro Reports Third Quarter 2025 Results
News Preview
Site Readiness Continues for Specialized Treatment Centers Envisioned to Support a Growing Number of Cell and Gene Therapy Trial Patients and Later Commercialization SOLANA BEACH, CA / ACCESS Newswire / November 6, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offerin...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.11.2025
ISIN: US18507C1036
Clearpoint Neuro Inc
CLPT
LISTED
NASDAQ
ClearPoint Neuro Announces Agreement to Acquire IRRAS
News Preview
Acquisition Will Further Expand the Potential of ClearPoint Neuro's Drug Delivery Portfolio While Immediately Adding New Indications and Commercial Scale Across a $0.5 Billion Market for the Treatment of Intracranial Bleeding SOLANA BEACH, CALIFORNIA / ACCESS Newswire / November 6, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Zealand Pharma conference call on November 13 at 2pm CET (8am ET) to present third quarter 2025 financial results
News Preview
Press Release – No. 15 / 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: DK0060055861
Chemometec A/S
CHEMM
LISTED
CPH
Growth in revenue and operating profit
News Preview
Trading statement for Q1 2025/26 (1 July - 30 September 2025)...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.11.2025
ISIN: US74366E1029
Protagonist Therapeutics Inc
PTGX
LISTED
NASDAQ
Protagonist Reports Third Quarter 2025 Financial Results and Provides Corporate Update
News Preview
Following the NDA submission for icotrokinra treatment of adults and adolescents with moderate to severe plaque psoriasis to the U.S. FDA in July, the European Medicines Agency (EMA) application was submitted in SeptemberRusfertide granted breakthrough designation for patients in Polycythemia Vera (PV) and the subject of four presentations includin...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.11.2025
ISIN: US03209R1032
Amphastar Pharmaceuticals Inc
AMPH
LISTED
NASDAQ
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025
News Preview
Reports Net Revenues of $191.8 million for the Three Months Ended September 30, 2025GAAP net income of $17.4 million, or $0.37 per share, for the third quarterAdjusted non-GAAP net income of $44.7 million, or $0.93 per share, for the third quarterCompany to hold a conference call today at 2:00 p.m. Pacific Time RANCHO CUCAMONGA, CA / ACCESS Newswir...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: DK0060027142
ALK-Abelló A/S
ALK B
LISTED
CPH
Invitation to the presentation of ALK’s first nine months (Q3) 2025 results on Thursday, 13 November 2025
News Preview
ALK (ALKB.DC / OMX: ALK B) will publish its results for the first nine months (Q3) of 2025 in the morning on Thursday, 13 November 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Genmab Announces Financial Results for the Nine Months of 2025
News Preview
November 6, 2025 Copenhagen, Denmark; Interim Report for the Nine Months Ended September 30, 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
AVTR INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Avantor, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that the Avantor class action lawsuit – captioned Building Trades Pension Fund of Western Pennsylvania v. Avantor, Inc., No. 25-cv-06187 (E.D. Pa.) – seeks to represent purchasers or acquirers of Avantor, Inc. (NYSE: AVTR) common stock and charges Avantor as well as certain of Avantor’...
Themefolio
Profiler
Peergroup
© Newsfile
06.11.2025
ISIN: CA65347A1021
Nextleaf Solutions Ltd.
OILS
LISTED
CSE
Nextleaf Announces Launch of New Recreational Cannabis Brand
News Preview
Vancouver, British Columbia--(Newsfile Corp. - November 6, 2025) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), a multi-patented life science company and Canadian cannabis processor, is pleased to announce the national launch of its new recreational brand, Yard.Yard is designed for adult-use...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US45337C1027
Incyte Corp
INCY
LISTED
NASDAQ
Incyte’s Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo and Pediatric Eczema
News Preview
Incyte (Nasdaq:INCY) today announced the expansion of its Moments of Clarity program, which amplifies the voices of people living with chronic immune-mediated skin conditions. This year, the initiative introduces six compelling new stories that spotlight the true lived experiences of people living with nonsegmental vitiligo and mild-to-moderate at...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US6373722023
National Research Corp
NRC
LISTED
NASDAQ
North Mississippi Health Services Chooses NRC Health to Elevate Care Experiences and Community Engagement
News Preview
North Mississippi Health Services (NMHS), a regional leader serving 24 counties across north Mississippi and northwest Alabama, has selected NRC Health as its long-term partner in healthcare experience management and strategic improvement.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: DE000BAY0017
Bayer AG
BAYN
LISTED
XETR
KERENDIA® (finerenone) Meets Primary Endpoint in Phase III Clinical Trial for Adults with Type 1 Diabetes and Chronic Kidney Disease
News Preview
Bayer today announced new Phase III investigational data from the pivotal FINE-ONE trial showing that KERENDIA® (finerenone) significantly reduced urine albumin-to-creatinine ratio (UACR) from baseline over six months by 25% compared to placebo in patients with type 1 diabetes (T1D) and chronic kidney disease (CKD) who were receiving standard of c...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US92337R1014
Vera Therapeutics Inc
VERA
LISTED
NASDAQ
Vera Therapeutics Announces Positive ORIGIN Phase 3 Data for Atacicept in IgA Nephropathy Presented at ASN Kidney Week 2025 and Published in the New England Journal of Medicine
News Preview
BRISBANE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced data from the ORIGIN Phase 3 trial of atacicept in IgA nephropathy (IgAN) were presented as a featured late-breaking oral presentation during the opening plenary session of the American Society of Nephrology (ASN) Kidney Week 2025 and simult...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
Shareholders that lost money on aTyr Pharma, Inc.(ATYR) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
News Preview
NEW YORK, Nov. 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of aTyr Pharma, Inc. (NASDAQ: ATYR).
Shareholders who purch...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
The Gross Law Firm Notifies Shareholders of MoonLake Immunotherapeutics(MLTX) of a Class Action Lawsuit and an Upcoming Deadline
News Preview
NEW YORK, Nov. 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of MoonLake Immunotherapeutics (NASDAQ: MLTX).
Shareholders...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
The Gross Law Firm Reminds Avantor, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 29, 2025 - AVTR
News Preview
NEW YORK, Nov. 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Avantor, Inc. (NYSE: AVTR).
Shareholders who purchased s...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
Class Action Filed Against DexCom, Inc. (DXCM) Seeking Recovery for Investors - Contact The Gross Law Firm
News Preview
NEW YORK, Nov. 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM).
Shareholders who purchased...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before November 10, 2025 to Discuss Your Rights - LNTH
News Preview
NEW YORK, Nov. 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Lantheus Holdings, Inc. (NASDAQ: LNTH).
Shareholders who...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Baxter International, Inc.(BAX) Shareholders
News Preview
NEW YORK, Nov. 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Baxter International, Inc. (NYSE: BAX).
Shareholders who...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
The Gross Law Firm Reminds Cytokinetics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 17, 2025 - CYTK
News Preview
NEW YORK, Nov. 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cytokinetics, Incorporated (NASDAQ: CYTK).
Shareholders...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Shareholders of Savara Inc. Should Contact The Gross Law Firm Before November 7, 2025 to Discuss Your Rights - SVRA
News Preview
NEW YORK, Nov. 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Savara Inc. (NASDAQ: SVRA).
Shareholders who purchased s...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US64132R4048
MetaVia Inc
NRBO
LISTED
NASDAQ
MetaVia Reports Third Quarter 2025 Financial Results and Provides Corporate Update
News Preview
Dosed the First Patient in the 8-Week 48 mg MAD Cohort of its Phase 1 Clinical Trial to Further Explore Non-Titrated Maximum Tolerated Dose of DA-1726 for the Treatment of Obesity; Top-Line Data Expected by Year-End 2025
$14.3 Million in Cash at...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US92337F1075
Veracyte Inc
VCYT
LISTED
NASDAQ
Veracyte to Participate in Upcoming Investor Conferences
News Preview
Veracyte, Inc. (Nasdaq: VCYT) a leading cancer diagnostics company, announced today it will participate in the following investor conferences.
Wolfe Research Healthcare Conference – New York, NY
Fireside Chat on November 17th at 10:00 a.m. Eastern Time
Jefferies Global Healthcare Conference – London, UK
Fireside Chat on November 20th at 11:30...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US80810D1037
Schrodinger Inc
SDGR
LISTED
NASDAQ
Schrödinger to Present at Jefferies London Healthcare Conference
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference. The live presentation will take place on Wednesday, November 19, at 4:00 p.m. GMT (11:00 a.m. ET).
The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be arch...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US70805E1091
Pennant Group Inc
PNTG
LISTED
NASDAQ
Pennant Group to Participate in the 2025 Stephens Annual Investment Conference
News Preview
Pennant Group to participate in 2025 Stephens Investment Conference...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: LU2458332611
Alvotech SA
ALVO
LISTED
ICE
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA
News Preview
REYKJAVIK, Iceland and LONDON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty,...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US1710774076
Niagen Bioscience Inc
CDXC
LISTED
NASDAQ
Niagen Bioscience Announces $10 Million Share Repurchase Program
News Preview
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its Board of Directors has approved a share repurchase program under which the Company is authorized to repurchase up to $10 million of outstanding common stock over approximate...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US8816242098
Teva Pharmaceutical Industries Limited
TEVA
LISTED
NYSE
Teva Canada Welcomes RAMQ Reimbursement Update Supporting Access to ADHD Treatments
News Preview
MONTRÉAL, Nov. 6, 2025 /CNW/ - Teva Canada welcomes the recent announcement from Québec's Ministry of Health regarding changes to the reimbursement framework for extended-release methylphenidate products. Effective December 11, 2025, the Régie de l'assurance maladie du Québec (RAMQ) will apply the "lowest price"...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US40131M1099
Guardant Health Inc
GH
LISTED
NASDAQ
New Study Validates Guardant Reveal Blood Test’s Effectiveness in Monitoring Chemotherapy Response
News Preview
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced new data demonstrating that its Guardant Reveal® blood test helps clinicians to assess the effectiveness of chemotherapy in patients with advanced solid tumors months earlier than conventional methods. This is the first robust clinical validation study of pan...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Consortium consisting of Nordic Capital and Permira announces preliminary result of the takeover offer to shareholders of Bavarian Nordic and that the Offer is withdrawn and will not be completed
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US4834971032
Kalvista Pharmaceuticals Inc
KALV
LISTED
NASDAQ
KalVista Pharmaceuticals Presents New Data Highlighting Patient Satisfaction with EKTERLY® (sebetralstat) and its Potential in Children Ages 2-11 at the ACAAI 2025 Annual Scientific Meeting
News Preview
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced new patient satisfaction and pediatrics data from its clinical studies of EKTERLY® (sebetralstat), the first and only oral on-demand treatment for hereditary angioedema (HAE), as well as physician and patient survey and consensus study data highlighting the substantial unmet need for sa...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Wellcare of Georgia Enhances Offering of Affordable, Quality Medicare Advantage and Medicare Prescription Drug Plans in 2026
News Preview
Medicare Advantage plans will be available to more than 51 million beneficiaries in 32 states; Prescription Drug Plans will continue to be offered nationwide.
New in 2026
Wellcare to transition Medicare-Medicaid Plans (MMPs) demonstration...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US28036F1057
Edgewise Therapeutics Inc
EWTX
LISTED
NASDAQ
Edgewise Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
News Preview
– Pivotal GRAND CANYON cohort
of sevasemten in Becker expected to read out in Q4 2026; building infrastructure to support potential commercial launch
–
–
MESA open-label extension trial of sevasemten in...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US6700021040
Novavax Inc
NVAX
LISTED
NASDAQ
Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights
News Preview
Total revenue of $70 million in the third quarter of 2025
Continued successful execution of Sanofi partnership with $225 million in milestones achieved year-to-date including $50 million earned on marketing authorization transfers...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US2289031005
Artivion Inc
AORT
LISTED
NYSE
Artivion Announces Treatment of First Patient with Arcevo LSA in ARTIZEN Pivotal Trial
News Preview
ATLANTA, Nov. 6, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the treatment of the first patient in the ARTIZEN pivotal trial, evaluating the safety and effectiveness of the Arcevo™ LSA Hybrid Stent Graft System ("Arcev...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: LU2458332611
Alvotech SA
ALVO
LISTED
ICE
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA
News Preview
REYKJAVIK, ICELAND and LONDON, UK (November 06, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, a...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US51654W1018
Lantern Pharma Inc.
LTRN
LISTED
NASDAQ
Lantern Pharma to Report Third Quarter 2025 Operating & Financial Results on November 13th, 2025 at 9:00 a.m. ET
News Preview
Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (“AI”) company developing targeted and transformative cancer therapies using its proprietary RADR® AI and machine learning (“ML”) platform with multiple clinical stage drug programs, today announced that it will host its third quarter 2025 operating and financial results webcast on Thu...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US81663L2007
GeneDx Holdings Corp
WGS
LISTED
NASDAQ
GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting
News Preview
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will unveil research findings during four key sessions at the 2025 National Society of Genetic Counselors (NSGC) Annual Meeting.
“GeneDx is at the forefront of genomic discovery, accelerating gene-disease insights, advancing long-rea...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US81728J1097
Sensus Healthcare, Inc.
SRTS
LISTED
NASDAQ
Sensus Healthcare Named to TIME’s America’s Growth Leaders of 2026
News Preview
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced that it has been named to TIME’s list of America’s Growth Leaders of 2026, developed in partnership with Statista Inc....
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US04635X1028
Astria Therapeutics Inc
ATXS
LISTED
NASDAQ
Astria Therapeutics Announces Final Positive Results from All Enrolled HAE Patients in the ALPHA-STAR Phase 1b/2 Trial of Navenibart
News Preview
Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced positive results from the full enrollment group of 29 patients in the ALPHA-STAR Phase 1b/2 clinical trial evaluating navenibart (STAR-0215), a monoclonal antibody inhibitor of pl...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US4622221004
Ionis Pharmaceuticals Inc
IONS
LISTED
NASDAQ
Ionis presents new data demonstrating long-term disease control with DAWNZERA™ (donidalorsen) at ACAAI 2025 Annual Meeting
News Preview
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced new long-term data for DAWNZERA™ (donidalorsen), the first and only RNA-targeted prophylactic medicine for hereditary angioedema (HAE), to be presented at the 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting in Orlando, Florida. Results demonstrat...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US14167L1035
CareDx Inc
CDNA
LISTED
NASDAQ
CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025
News Preview
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced new data presentations featuring CareDx technologies at American Society of...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US75120L1008
Rallybio Corp
RLYB
LISTED
NASDAQ
Rallybio Reports Third Quarter 2025 Financial Results and Provides Business Updates
News Preview
Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today reported financial results for the third quarter ended September 30, 2025, and provided an update on recent company developments.
“In the third quarter, we con...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
